| Stage | SYM | % of rev | NDSN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $721M | 100.00% | $818M | 100.00% | NDSN ×1.13 |
| Gross profit | $161M | 22.32% | $454M | 55.49% | NDSN +33.2pp |
| Operating income | $33M | 4.56% | $223M | 27.28% | NDSN +22.7pp |
| Pre-tax income | $63M | 8.81% | $186M | 22.74% | NDSN +13.9pp |
| Net income | $55M | 7.63% | $153M | 18.69% | NDSN +11.1pp |
| Stage | SYM | NDSN | Gap · A − B |
|---|---|---|---|
| Revenue | $721M100.00% | $818M100.00% | NDSN ×1.13 |
| Gross profit | 22.32%$161M | 55.49%$454M | NDSN +33.2pp |
| Operating income | 4.56%$33M | 27.28%$223M | NDSN +22.7pp |
| Pre-tax income | 8.81%$63M | 22.74%$186M | NDSN +13.9pp |
| Net income |
| 7.63%$55M |
| 18.69%$153M |
| NDSN +11.1pp |
No disclosed counterparties: NDSN.
None